Title |
Current regulatory approaches for accessing potential COVID-19 therapies
|
---|---|
Published in |
Journal of Pharmaceutical Policy and Practice, May 2020
|
DOI | 10.1186/s40545-020-00222-6 |
Pubmed ID | |
Authors |
Vesa Halimi, Armond Daci, Simona Stojanovska, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandra Grozdanova |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 67% |
Canada | 1 | 17% |
Unknown | 1 | 17% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 3 | 50% |
Members of the public | 2 | 33% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 59 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 14% |
Other | 6 | 10% |
Student > Ph. D. Student | 6 | 10% |
Professor | 5 | 8% |
Student > Master | 4 | 7% |
Other | 15 | 25% |
Unknown | 15 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 20% |
Agricultural and Biological Sciences | 4 | 7% |
Biochemistry, Genetics and Molecular Biology | 4 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
Psychology | 3 | 5% |
Other | 15 | 25% |
Unknown | 17 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2020.
All research outputs
#6,914,535
of 22,973,051 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#166
of 411 outputs
Outputs of similar age
#144,624
of 388,500 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#14
of 23 outputs
Altmetric has tracked 22,973,051 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 411 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 388,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.